Viewing Study NCT02662868


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-01-24 @ 8:07 PM
Study NCT ID: NCT02662868
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2016-01-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
Sponsor: Latin American Cooperative Oncology Group
Organization:

Study Overview

Official Title: Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
Status: COMPLETED
Status Verified Date: 2017-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to describe demographics and socioeconomics characteristics associated to the diagnosis of metastatic breast cancer in Brazil.
Detailed Description: The primary aim of this study is to characterize patients and treatments of metastatic breast cancer in Brazil. Other specific aims are:

* to describe patients demographics and socioeconomic characteristics
* to describe the BC pathological characterization
* to describe treatment (describe each treatment with dates start-end, cycles, dosing, sequence and line of treatment, reason for discontinuation)
* to analyze patients outcome (time to progression, site of metastasis, progression free survival (PFS), overall survival (OS), skeletal related events (SRE))

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: